* Now classified as Oncocytic carcinoma of the thyroid (formerly Hürthle cell carcinoma) ‡Based on the treatment options available at that time; following genetic testing, treatment with a selective RET inhibitor was offered to the patient. This evidence concerns the gene RET and Thyroid Gland Oncocytic Follicular Carcinoma.